Alkermes to Participate in the Goldman Sachs Healthcare Conference

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) announced its participation in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022, at 2:40 p.m. PT (5:40 p.m. ET). The event will include a fireside chat with management, accessible via a live webcast on the company’s website and archived for 14 days. Alkermes, headquartered in Dublin, focuses on developing innovative medicines in neuroscience and oncology, with products for conditions like alcohol and opioid dependence, schizophrenia, and more.

DUBLIN, June 8, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Goldman Sachs 43^rd Annual Global Healthcare Conference on Wednesday, June 15, 2022 at 2:40 p.m. PT (5:40 p.m. ET/10:40 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-goldman-sachs-healthcare-conference-301563683.html

SOURCE Alkermes plc

FAQ

When is Alkermes participating in the Goldman Sachs Healthcare Conference?

Alkermes will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022, at 2:40 p.m. PT.

Where can I watch the Alkermes conference webcast?

The conference webcast can be accessed on Alkermes' website under the Investors tab.

What markets is Alkermes focused on?

Alkermes is focused on neuroscience and oncology, developing medicines for alcohol and opioid dependence, schizophrenia, and bipolar disorder.

What is the ticker symbol for Alkermes?

The ticker symbol for Alkermes is ALKS.